A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss

To examine the safety and effects on hearing thresholds of two single-doses of PF-04958242.

  1. Tinnitus Talk
    The objective of this study is to examine the safety, tolerability, and effects on hearing thresholds of two single doses of PF-04958242 and placebo in subjects with age-related hearing loss.


    Estimated Enrollment: 42
    Study Start Date: December 2011
    Estimated Study Completion Date: February 2013
    Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)